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Abstract
To better understand splicing regulation, we used a cell-based screen to identify ten diverse motifs 
that inhibit splicing from intron. Each motif was validated in another human cell type and gene 
context, and their presence correlated with in vivo splicing changes. All motifs exhibited exonic 
splicing enhancer or silencer activity, and grouping these motifs based on their distributions 
yielded clusters with distinct patterns of context-dependent activity. Candidate regulatory factors 
associated with each motif were identified, recovering 24 known and novel splicing regulators. 
Specific domains in selected factors were sufficient to confer ISS activity. Many factors bound 
multiple distinct motifs with similar affinity, and all motifs were recognized by multiple factors, 
revealing a complex, overlapping network of protein:RNA interactions. This arrangement enables 
individual cis-element to function differently in distinct cellular contexts depending on the 
spectrum of regulatory factors present.
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The specificity of splicing is mainly defined by splice site and branch point sequences 
located near the 5' and 3' ends of introns. Beyond these core signals, multiple cis-acting 
splicing regulatory elements (SREs) play essential roles in controlling splicing specificity. 
These SREs are conventionally classified as exonic splicing enhancers (ESEs) or silencers 
(ESSs), and intronic splicing enhancers (ISEs) or silencers (ISSs). SREs generally function 
by recruiting trans-acting splicing factors that interact favorably or unfavorably with the 
core splicing machinery such as the small nuclear ribonucleoprotein (snRNP) complexes U1 
or U2 1,2. In mammals, splicing of each gene is controlled by multiple SREs and 
corresponding splicing factors, whose combinatorial actions determine the final splicing 
outcome 3.
To determine comprehensive rules of splicing regulation, systematic identification of SREs 
and the associated trans-acting factors is needed. Significant progress has been made 
recently toward comprehensive identification of exonic SREs 4–9. However, fewer large-
scale analyses of intronic SREs have been conducted 9,10 despite the expectation that 
intronic elements are as important in splicing regulation as their exonic counterparts. 
Intronic SREs are likely recognized by a greater diversity of proteins, including proteins of 
the hnRNP class as well as others 2, but knowledge of these factors remains incomplete.
The best-known ISSs include binding sites for the splicing repressors hnRNP I (or PTB) and 
hnRNP A1 11,12, as well as CA-rich sequences bound by hnRNP L 13. PTB can bind to ISSs 
and inhibit the transition from an exon-definition complex to an intron-spanning 
spliceosome 11, whereas hnRNP A1 may block recognition of splice sites by cooperative 
propagation along the pre-mRNA from primary binding sites introns 12 or by other 
mechanisms 14. Overall, the sequence composition and mechanisms of action of known ISSs 
are quite diverse, suggesting that many more ISSs remain to be discovered.
To systematically identify ISSs, we screened a random library for short sequences that 
inhibit splicing in cultured human cells. All identified ISS motifs enhanced or inhibited exon 
inclusion when inserted into exons, and most altered the choice of alternative 5′ splice sites 
(5′SS). Analysis of genomic distributions of these motifs identified four classes of motifs, 
each having similar patterns of context-dependent splicing regulatory activity. Identification 
of trans-acting splicing factors for each motif revealed a densely connected network, 
suggesting that individual exons are often controlled by multiple factors with overlapping 
RNA-binding specificities that function through the same element at different temporal or 
cellular contexts.
Results
Identification of 102 ISSs using a cell-based screen
To unbiasedly identify ISS sequences, we developed a cell-based screen called FAS-ISS 
(fluorescence activated screen of ISS). We constructed a reporter gene (pZW11) whose 
exons 1 and 3 form a complete mRNA encoding the GFP, and exon 2 is a small constitutive 
exon (exon 6 of human SIRT1) that is normally included in ~100% of mRNAs 
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(Supplementary Table 1). Insertion of known ISS containing binding sites of hnRNP I (Test 
1) or hnRNP A1 (Test 2) in the downstream intron of exon 2 caused partial skipping of this 
exon. Following transient transfection with the ISS-containing reporters, we observed about 
15–35% GFP-positive cells (Fig. 1a), whereas cells with the control construct had negligible 
fluorescence (< 5% green cells). We confirmed that splicing patterns were consistent with 
the GFP expression via RT-PCR (Fig. 1b).
We inserted a random pool of decanucleotides (10mers) at 17 nt downstream of the test 
exon, far enough into the intron to avoid interference with the 5′SS. We transformed the 
resulting library into sufficient numbers of E. coli to achieve ~2-fold coverage of possible 
DNA 10mers. To evaluate the library quality, we randomly picked 24 colonies for plasmid 
extraction and sequencing, and found that all had 10 base inserts with no bias at any 
position. We further transfected the resulting library into 293-FlpIn cells and sequenced 
inserted fragments from a pool of stably transfected cells to ensure no sequence bias (Fig. 
1c).
The reporter was inserted by site-specific recombination into a single target site of 293-FlpIn 
cell line. Typically about one in 1000–5000 cells was GFP positive (Supplementary Fig. 1a). 
These GFP positive cells were sorted by FACS, clonally expanded, and putative ISS 
sequences were identified by PCR and sequencing (Fig. 1d). We conducted 315 
transfections in 21 batches, from which 114 ISS 10mers were identified, 102 of which were 
unique (In a few cases, 9mers or 11mers were identified, see Supplementary Table 2). We 
identified nine 10mers at least twice in independent transfections and 19 pairs differed by a 
single nucleotide, suggesting that the screen approached saturation. These ISS 10mers could 
be readily clustered by sequence similarity (Fig. 1d). We inserted 16 of the recovered ISS 
10mers (asterisks in Fig. 1d) spanning all clusters back into the reporter pZW11 to assess 
their activity with a transient transfection assay 7. All 16 candidates produced 20–45% GFP-
positive cells, compared to < 3% for random controls (Supplementary Fig. 1b). The 
percentage of green cells was presumably limited by transfection efficiency as stable lines 
containing the same 10mers generally yielded a higher fraction of green cells.
Identification and validation of ten core ISS motifs
To extract core motifs with intrinsic ISS activity, we used statistical over-representation in 
the recovered 10mer set as a criterion 7. Forty-one 5mers occurred at least five times in the 
recovered sequences, about 3-fold higher than expected (p < 10−4, based on 10,000 
samplings of random 10mers). Using similar criteria, we identified over-represented 6mers 
and 7mers, and these k-mers (k = 5, 6, 7) were then clustered by sequence similarity and 
multiply aligned using CLUSTALW to identify candidate ISS motifs. At a cutoff 
dissimilarity score of 3.6, most ISS k-mers fell into one of nine clusters of at least six 
sequences each, which were designated FAS-ISS groups A to I (Fig. 2a). We also analyzed 
an isolated 7-mer designated group U (unclustered). Such clustering was inherently inexact, 
as the number of clusters may vary depending on the dissimilarity cutoff. However, this 
clustering was still informative as it provided distinct consensus motifs for further analyses. 
The group A consensus (CTCCT) resembled the binding motif of PTB and of its neuronal 
homolog, nPTB, and the group I consensus (TAGG) matched the hnRNP A1 motif. Both 
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factors were known to inhibit splicing from intronic binding sites 11,12,14, confirming the 
ability of our screen to identify authentic ISS motifs.
The ISSs identified had higher content of A (37%) or T (28%) and lower levels of C (19%) 
or G (16%) (Supplementary Fig. 1c). This composition was distinct from previously 
identified exonic SREs, where ESEs were largely A or G-rich 5,6 and ESSs were G or T-
rich 6,7. Considering individual motifs, FAS-ISSs more often resembled the A or G-rich ESE 
motifs than ESSs. Consistently, there are examples where SR proteins promoted splicing 
from exonic sites but inhibited splicing from intronic sites 15–18. At the dinucleotide level, 
AC, CA and GA were over-represented in FAS-ISSs, and CG was under-represented. By 
comparison, AC and GA were over-represented in ESEs and under-represented in ESSs 5,7, 
again suggesting similarity between ISSs and ESEs (Supplementary Fig. 1d). An exception 
was the ISS group I (consensus TAGG) that matched motifs bound by hnRNP A1, which 
typically represses splicing from intronic and exonic locations 19–21.
There are additional ISSs undetectable by our screen, such as motifs whose corresponding 
trans-factors were poorly expressed in 293T cells or motifs with weak activity to repress the 
test exon in our reporter. Our screen might also miss very long ISSs, or those that function 
only when presented in multiple copies. A previous screen for intronic SREs using a reporter 
based on nonsense-mediated mRNA decay called SPLICE 10 predominantly identified G-
rich and G or T-rich elements. The SPLICE elements exhibited limited overlap with the ISS 
motifs identified here, but overlapped somewhat with motifs identified in a parallel screen 
for ISE 22.
To test whether the over-represented motifs possess intrinsic ISS activity, we analyzed a 
representative 6mer or 7mer (an “exemplar”) from each ISS group (Fig. 2a). We used a 
mutant of the exemplar differing by 1–3 nt as a control (Supplementary Table 3 and 4). 
Using transient transfection, we observed ISS activity for each exemplar as judged by 
generation of GFP-positive cells (Fig. 2b). Control sequences all yielded significantly 
decreased levels of green cells (p < 0.05, paired T test), and the mutations of groups A, C, F 
and U essentially abolished ISS activity. We further confirmed these results by semi-
quantitative RT-PCR (Fig. 2c). These observations suggested that our approach successfully 
extracted core ISS motifs, and motivated our use of these exemplars as representatives of the 
ISS groups in the remainder of this study.
To examine the functionality of FAS-ISSs in genomic scale, we determined whether the 
presence of these ISSs affected alternative splicing patterns in Human BodyMap 2.0 dataset. 
We searched the downstream of alternative exons for the ISS sequences and for a set of 
decoy sequences generated by permuting the ISSs. For each ISS group we compared the PSI 
(percent-spliced-in) values of the exons with an ISS to those associated with a decoy. Eight 
out of ten ISS groups had decreased inclusion rate than their decoy sets, with four groups (B, 
E, D and G) having significant changes, whereas only one ISS (I) showed substantially 
increased PSI (Supplementary Table 5), suggesting that most FAS-ISSs can indeed interpret 
the splicing of alternative exons from RNA-seq data.
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ISSs function in a heterologous intron and cell type
SREs generally function through recruiting specific trans-factors whose activities may vary 
in different cell types and pre-mRNA contexts. Thus we tested whether the FAS-ISS motifs 
were specific to the cell type used in original screen by transiently transfecting HeLa cells 
with reporters containing the same exemplars. While no skipping of the test exon was 
observed in reporters containing randomly chosen sequences, exemplars of all 10 ISS groups 
caused a significant degree of exon skipping, and most mutants showed decreased levels of 
exon skipping in HeLa cells (Fig. 2d).
To test whether these motifs had silencer activity in a second pre-mRNA context, we 
constructed a new splicing reporter by inserting exon 2 of Chinese hamster dihydrofolate 
reductase gene and portions of its flanking introns between two GFP exons. We inserted 
exemplars of ten ISS groups at downstream of this exon (Supplementary Tables 3, 4) and 
assayed exon inclusion. We observed that 8 of the 10 ISS motifs exhibited silencer activity 
in this heterologous intron compared to the controls (Fig. 2e). Two exceptions were groups 
F and I, whose exon inclusion levels were not markedly different from controls, even though 
sequences similar to the group I motif had been shown to function as ISSs 20. Taken 
together, these data indicated that although the screen was conducted with a single reporter 
in a specific cell line, all the obtained ISS motifs had activity across different cell types and 
most functioned in a heterologous intron context.
ISSs activate or repress splicing from exonic locations
The activities of SREs often depend on their locations relative to nearby splice sites, 
collectively described as the “context dependence” of SREs 1. To determine whether FAS-
ISS motifs function in other pre-mRNA locations, we inserted the ISS exemplars into the 
exon of a modular splicing reporter (Fig. 3a). Strikingly, all ISSs functioned either as ESEs 
to promote exon inclusion (exemplars C, D, E, F, G, and U) or as ESSs to inhibit exon 
inclusion (exemplars A, H, I). We observed similar functions for the ISSs in both HeLa and 
293T cells (Supplementary Fig. 2a). The only exception was exemplar B, which functioned 
as an ESE in 293T cells but lacked detectable ESE activity in HeLa cells.
Using a reporter with two competing 5′SS, we previously found that all FAS-ESSs inhibited 
use of the proximal 5′SS when inserted between the two sites, whereas most ESEs promoted 
use of this site 23. When inserting each ISS exemplar between competing 5′SS of the same 
reporter, we observed more diverse activities (Fig. 3b and Supplementary Fig. 2b): three ISS 
motifs (C, D and E) showed “ESE-like” activity by promoting use of the proximal site, 
whereas most ISSs (A, B, F, G, H and I) inhibited the proximal site usage (i.e., ESS-like).
We scanned the Illumina’s Human BodyMap 2.0 dataset for alternative exons containing 
either ISS sequences or their decoys, and examined the correlation of ISS with the change of 
exon inclusion rate. The ISSs with ESS activity (group A, H, and I, shown in red) all showed 
remarkably decreased PSI values compared to decoy set (Supplementary Table 5), whereas 
most ISSs with ESE activity increased the PSI value although only groups D and G 
produced substantial increases. Similar analyses for exons with alternative 5′SS did not 
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produce statistically significant results, probably because the sample size was small in this 
case.
Genomic distributions define distinct ISS clusters
Specific classes of SREs often have characteristic distribution patterns in pre-mRNAs. For 
example, many ESEs are enriched in constitutive exons (CE) relative to introns and in exons 
with weak splice sites, consistent with their function in enhancing exon inclusion 5,6. 
Conversely, ESSs are enriched in introns relative to exons and in skipped exons (SE) 
compared to CE, consistent with their function in repressing exon inclusion and use of decoy 
splice sites 7,23. Thus the distributional biases of SREs reflect their functions in different 
pre-mRNA locations and may be used in SRE classification 24. Previously we observed that 
all FAS-ESSs exhibited similar distribution biases 7,23. By contrast, the relative frequencies 
of different ISS groups varied substantially in CE, SE and flanking introns – e.g., some 
groups were enriched in CEs, others in SEs or introns – revealing unexpected complexity 
(Supplementary Fig. 3).
To explore this complexity and uncover any new patterns, we measured the relative 
enrichment of FAS-ISSs in thirteen pairs of pre-mRNA regions (Supplementary Table 6), 
and analyzed the vectors of enrichment values using principal component analysis (PCA). 
The distribution of each ISS group in space of the first two principal components, which 
represented 86% of the variance, suggested the existence of 4 clusters of motifs (numbered 
by cluster size) including two tight clusters (Cluster 1: motifs C, D, E, G, and Cluster 3: B, 
U), the looser Cluster 2 (A, H, I), and the isolated motif F as Cluster 4 (Fig. 4a). This 
classification corresponded closely with the context-dependent activities of the motifs 
observed above (Fig. 4b). Cluster 1 motifs were characterized by enrichment in CEs relative 
to SEs and introns, and by a convex distribution along exons (i.e. enriched near both ends 
relative to the centers of exons). All ISSs in this cluster promoted inclusion from an exonic 
location and favored proximal 5'SS usage when located between competing 5'SS (Fig. 3), a 
pattern typical of ESEs 23. Cluster 2 motifs were enriched in introns and SEs relative to CEs 
and had variable exonic distributions. Conversely they inhibited exon inclusion and 
proximal 5'SS usage from an exonic location (Fig. 3 and 4b), similar to ESSs 23. Motifs of 
Cluster 3 were exon-enriched but had monotone increasing along exons. Unlike canonical 
ESEs, these ISSs promoted exon inclusion but inhibited (or did not affect) proximal 5'SS 
usage. Motif F distributed differently from all other motifs (Fig. 4a). It was intron-enriched 
like Cluster 2, but promoted exon inclusion like Clusters 1 and 3. Taken together, all six 
exon-enriched ISS motifs promoted exon inclusion and all but one of intron-enriched motifs 
inhibited exon inclusion, consistent with the RNA-seq results in endogenous exons (Fig. 4b). 
The existence of 4 clusters of ISS motifs with distinct patterns of activity contrasts with the 
relatively homogeneous distributions and activities of FAS-ESSs, suggesting that the 
functions of intronic SREs are more diverse.
Identification of ISS binding factors
SREs generally function through recruiting trans-factors to affect splicing 1. Alternatively, 
they affect splicing by forming inhibitory structures to block recognition of splice signals 25 
or changing the long range RNA structure 26, or by altering the spliceosome assembly 
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dynamics 9. Since we didn’t detect particular changes of pre-mRNA structures in the 
original intron containing ISSs versus control 10mers using Mfold (not shown) and most 
FAS-ISS motifs had silencer activity in a heterologous intron (Fig. 3b), they are most likely 
to function through recruiting inhibitory trans-factors. To unbiasedly identify associated 
factors, we incubated a short RNA fragment of ISS exemplars with whole cell extract, and 
isolated RNA-protein complexes with streptavidin beads and identified proteins specifically 
bound by ISSs with mass spectrometry 27. (Fig. 5a).
Our approach was illustrated using the exemplar from group U (CACACCA). Four major 
bands were present in the exemplar RNA but were reduced or absent from controls (Fig. 5b). 
The strongest band (no. 2) corresponded to hnRNP L that is known to bind CA-rich 
elements 13,28. Band 1 contained two similar proteins (IGF-II mRNA binding proteins 1 and 
3) that are involved in RNA trafficking and translation 29. Band 3 was identified as Y box 
binding protein 1 (YB-1) that can bind to both DNA and RNA. YB-1 was reported to 
influence alternative splicing of CD44 30, but its RNA binding specificity was remained 
unclear. Band 4 contained an alternative isoform of hnRNP L and the protein SF2P32. 
SF2P32 was originally identified through co-purification with the splicing factor SRSF1 31 
but was later localized to the mitochondrial matrix 32, suggesting that it may be a co-
purification artifact resulting from its ability to bind other RNA-binding proteins (RBPs). 
Thus, hnRNP L and YB-1 were identified as putative splicing repressors associated with 
motif U.
We conducted RNAi and over-expression of identified proteins in cells transfected with 
splicing reporters containing cognate ISS. Knockdown of either hnRNP L or YB-1 
derepressed the inclusion of an exon containing the group U ISS, whereas RNAi of an 
unrelated RBP (GRSF-1) had no effect (Fig. 5c, supplementary Fig. 4a). These splicing 
inhibitory activities were specific to the CA-rich motif, as the knockdown had no effect on 
the reporter containing another ISS (group D). Conversely, the over-expression of YB-1, and 
to a lesser extent hnRNP L, enhanced exon skipping in the reporter containing the CA-rich 
ISS but not in a similar reporter containing other ISSs (Fig. 5d, supplementary Fig. 4b). 
These data implicated hnRNP L and YB-1 as factors responsible for the ISS activity of motif 
U. Interestingly, simultaneous knockdown of hnRNP L and YB-1 had similar effects as 
RNAi of each protein alone, and over-expression of both factors repressed splicing less than 
over-expression of YB-1, suggesting that ISS-dependent splicing repression by YB-1 and 
hnRNP L is not simply additive. The two proteins did not directly interact with each other as 
judged by co-immunoprecipitation assay, although the indirect association through RNA 
bridges was observed (Fig. 5e). The over-expression of YB-1 can rescue the RNAi effect of 
hnRNP L in splicing reporters containing cognate ISS but not control ISS (Fig. 5f). 
Therefore the two proteins might compete for binding to the same ISS, with YB-1 repressing 
splicing more strongly than hnRNP L.
Identification of putative trans-factors for all ISS motifs
We expanded the affinity purifications to identify trans-factors for other ISS motifs (groups 
B to I). Group A was excluded because it matched known binding motifs of PTB and nPTB 
that inhibit splicing from intronic positions33–36. We purified the RNA-protein complexes 
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associated with these ISSs and two additional negative controls (mutant exemplars from 
groups C and F) and resolved total proteins by SDS-PAGE (Supplementary Fig. 5).
Each ISS motif exhibited a distinct protein binding profile (Supplementary Fig. 5), implying 
sequence-specific binding of RNAs by associated factors. The protein bands present only in 
ISS samples were identified by mass spectrometry. Most of identified factors were known 
RBPs or contained putative RNA binding domains, while a few were annotated as DNA 
binding or cytoskeletal proteins (Supplementary Table 7). Some proteins may have been 
identified through indirect interaction with other specific RBPs. For example, multiple 
proteins in U1 snRNP (e.g. U1-70k, U1A, SmD1 and SmD2) co-purified with ISS motif E, a 
purine-rich element recognized by SFRS1 (Table 1). Since SRSF1 was detected as a 
component of U1 snRNP complex 37, these U1 snRNP core components probably bound to 
group E ISS indirectly through interacting with SFRS1.
We also identified some abundant proteins that probably bound RNA in a non-sequence-
specific manner (e.g., La protein was co-purified with 3 motifs and nucleolin co-purified 
with motif C). Of the 24 identified putative sequence-specific splicing factors (Table 1), 12 
belonged to the hnRNP class, many of which were previously shown to regulate splicing, 
including hnRNPs A1, A2, H1, I and L 35,36,38–40. Several non-hnRNP proteins have not 
previously been reported to regulate splicing.
A complex interaction map between ISSs and trans-factors
Most of the identified RBPs contained multiple RNA binding domains, and many appeared 
to have flexible specificity capable of binding multiple distinct motifs. Conversely, 
individual ISS motifs were recognized by multiple proteins, suggesting that the relationship 
between splicing factors and ISS motifs may be most compactly represented by an RNA-
protein connectivity map (Fig. 6a) rather than a table of one-to-one interactions. The ISS 
motifs from the same cluster (Fig. 4a) tended to bind similar proteins, while a few specific 
proteins (e.g., members of hnRNP A, D and H families) recognized motifs belonging to two 
different clusters.
The complexity of the RNA-protein connectivity map raised questions about the extent of 
direct binding. An extreme case was presented by ISS motifs F, H and I that bound to a 
highly overlapping set of factors despite significant sequence diversity. These factors 
included hnRNP A0, A1, A2, A3, D0, DL and DAZAP1, most containing two N-terminal 
RRM domains and a C-terminal Gly-rich motif. We used surface plasmon resonance (SPR) 
to determine direct interactions between the ISS exemplar and single purified protein 
(hnRNP A0, A1, A2, D0 and DL were tested, hnRNP A3 failed to express). Notably, the ISS 
motifs F, H and I can all directly bind to multiple proteins in the hnRNP A family (A0, A1, 
A2) and to hnRNP D0 and hnRNP DL (Fig. 6b, supplementary Fig. 6), although each 
protein exhibited somewhat different affinities for individual exemplar. For example, 
hnRNP A0 and D0 preferentially bound the A or U-rich motif H, while hnRNP DL showed 
preferential binding to the motif I. Nevertheless, the binding affinities to distinct motifs were 
fairly similar, with apparent Kd values in the range 10–100 nM for each pair (unpublished), 
suggesting that the RNA-protein connections detected in our affinity purification typically 
reflected direct interactions.
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Gly-rich and RS domains inhibit splicing from introns
The hnRNP proteins comprised roughly half of the putative trans-factors identified above, 
many containing regions of repetitive sequence like Gly-rich domains (e.g. hnRNP A1 
family). In addition, we found one SR protein (SRSF1) binding to ISSs of groups D and E. It 
is well established that SRSF1 activates splicing by binding to ESEs and hnRNP A1 inhibits 
splicing by recognizing ESSs (reviewed in 1,41). Both of these prototypical splicing factors 
have modular structures, recognizing RNA targets through their N-terminal RRM domains 
and affecting splicing through C-terminal functional domains (RS or Gly-rich) 19,42. 
However other mechanism may exist, as the RS domains were shown to recognize RNA 
near branch-point to promote splicing 43. When tethered to an exon, most RS domains can 
activate exon splicing 42,44,45 whereas the Gly-rich domain of A1 can suppress 
splicing 19,45. Since both hnRNP A1 and SRSF1 were identified as putative ISS-associated 
splicing repressors, we speculated that their RS and Gly-rich domains can inhibit splicing 
from an intronic location.
We tested this hypothesis by fusing an RS domain (from SRSF1) or Gly-rich domain (from 
hnRNP A1) with modified pumilio (PUF) domains that recognized specific 8 nt RNA 
sequences 46. Two PUF domains, the PUF(3-2) specifically recognizing UGUAUGUA and 
the PUF(6-2) recognizing UUGAUAUA 45,46, were combined with the RS or Gly-rich 
domain (from SRSF1 or hnRNP A1) yielded four fusion proteins that were co-transfected 
with the splicing reporter containing cognate target sites (Fig. 6c). As predicted, both the RS 
and Gly-rich domain inhibited exon inclusion from downstream of the 5′SS, whereas the 
binding of PUF domain itself had no detectable effect (Fig. 6c, left). Splicing inhibition was 
detected only in the cognate PUF-RNA pairs but not between non-cognate pairs.
To examine whether the splicing inhibition at intronic locations is a general activity of the 
RS and Gly-rich domains, additional proteins were generated by fusing PUF(6-2) with the 
RS domains of SFRS2, SFRS5 and SFRS7, the Gly-rich domains of hnRNP A1, A2 and A3, 
a short peptide of (RS)6 or a 19-aa Gly-rich sequence (Fig. 6c right panel). Remarkably, 
compared to the controls (lanes 13 and 14), all of these fusions strongly inhibited inclusion 
of the exon containing the cognate target at downstream introns, suggesting that a 
polypeptide containing RS repeats or a short Gly-rich fragment is sufficient to inhibit 
splicing when recruited downstream of an exon.
Discussion
We adapted a cell-based screening approach developed previously for comprehensive 
identification of ESSs 7 to identify ten distinct ISS motifs. The similarities in the reporters 
and other aspects of the two screens make comparison of their results worthwhile to 
understand intrinsic differences between exonic and intronic silencers. All the newly 
identified ISS motifs had activity in a second cell type, and most functioned in a 
heterologous intron, supporting their functional modularity and portability as observed for 
ESSs. However, in some respects ISSs behaved very differently from ESSs, exhibiting far 
greater diversity and complexity of function.
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The first clue to these differences was the greater sequence complexity of the ISSs. While 
the ESSs were G or T-rich (74% G+T), the sequence bias in the ISSs was less pronounced 
(65% A+T), and a larger number of ISS motifs were identified (10 ISSs versus 7 ESSs). All 
ESS motifs had similar patterns of distributional bias 7,23 and were able to repress intron-
proximal 5'SS and 3'SS, demonstrating remarkable consistency of activity 23. By contrast, 
the ISS motifs had diverse patterns of distributional bias, with different motifs being most 
enriched in either CE, SE or introns, and having either convex or increasing frequency along 
exons. Placement of the ISSs into exonic locations revealed a diversity of functions, 
including activation or repression of exon inclusion and inhibition or enhancement of 
proximal 5'SS usage. Such context-dependent activities matched the genomic distributional 
patterns, emphasizing the need for subclassification of ISSs. We used a PCA approach to 
define four clusters of functionally different ISS motifs based on distinct genomic 
distribution patterns, thus the motifs within same cluster may still have quite different 
consensus sequence. The associated trans-factors can act through multiple motifs and 
sometimes even across multiple PCA classes, suggesting this classification is likely to be 
improved by taking into account of trans-factors.
It has been noted that the sequence specificity of most RBPs is relatively low, causing high 
noise in affinity purifications of proteins associated with ISSs. Our method had a number of 
improvements to minimize such noise, which include using a short RNA (21–23 nt) with 3 
copies of ISS exemplars to increase affinity, using a long spacer separating biotin from RNA 
to increase the RNA accessibility, and incubating in a large volume (i.e. low protein 
concentration) for an extended time (> 4 h) to help reach binding equilibrium. Many of the 
identified proteins probably regulate splicing as suggested in this study and by other labs, 
but some may also function in other RNA processing pathways. For example, G3BP-1 was 
reported to mediate RNA translation and degradation 47 and GRSF-1 was shown to affect 
translation 48. Even the canonical splicing factors like SRSF1 or hnRNP A1 were reported to 
control mRNA translation or degradation 49,50.
Most factors bound multiple ISS motifs and each motif was recognized by multiple factors, 
supporting a complex network of protein-RNA interactions responsible for ISS activity. 
Such overlapping specificities may enable a variety of regulatory relationships. For example, 
multiple factors with similar regulatory activities may bind the same motif to confer 
functional redundancy, whereas antagonism would be expected in cases where one factor 
can displace another and confer opposite splicing regulatory function 22. Other relationships 
could provide subtler tuning of splicing levels, e.g., displacement of a repressive factor by 
another repressive factor with stronger or weaker activity, or recruitment of distinct splicing 
regulatory complexes to a given site in the pre-mRNA. The relationship between PTB and 
nPTB may illustrate some of these regulatory relationships, e.g., in HeLa cells nPTB can 
compensate for PTB depletion 34, while in neural development replacement of PTB by 
nPTB may alter the regulation of a substantial alternative splicing program 51.
A variety of regulatory relationships are possible in the examples identified here. For 
example, both hnRNP L and YB-1 bound ISS motif U. While over-expression or depletion 
of either factors was sufficient to repress or derepress splicing respectively, their relationship 
is not simple redundancy. Instead they may compete for the same site, with hnRNP L 
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repressing splicing less strongly than YB-1 (Fig. 5c). As another example, ISS motifs D and 
E were both recognized by SFRS1 and hnRNP H1 that typically have the opposite pattern of 
activity 38,52–54. Our data suggested these factors might antagonistically regulate introns 
containing motifs D or E - in 293T cells, binding of motifs D and E by SFRS1 or other 
intron-repressive factors likely predominates, since these motifs have ISS activity. The less-
characterized factors RBM45 and GRSF-1 also bind motif D, potentially adding additional 
regulatory complexity via this motif.
Our analyses using fusions of candidate splicing regulatory domains indicated that the 
requirements for splicing repression were surprisingly minimal. Tethering of an RS or Gly-
rich domain from any of various SR or hnRNP proteins (or even a short RS repeat or Gly-
rich peptide) at downstream of an exon was sufficient to repress splicing (Fig. 6c). This 
observation raises the possibility that many other proteins with similar domains also control 
splicing when binding to pre-mRNA. An analysis of human proteome identified a total of 24 
human proteins that contain both a short Gly-rich segment and at least one RRM domain, 




All splicing reporters were constructed from a backbone vector, pZW1, which contains a 
multi-cloning site between two GFP exons 7. The random sequence library was generated 
from a foldback primer extended with Klenow and digested and ligated into pZW11 that 
contain a multi-cloning site at downstream of a constitutive exon. To test ISSs in a 
heterologous context, a new reporter (pZW2C) was constructed by inserting the exon 2 of 
DHFR gene and part of its flanking introns between the two GFP exons. The reporter with 
competing 5′SS and the modular splicing reporter were described previously 23,55,56. 
Additional details were described in supplemental note.
Cell culture and transfections
293 cells and HeLa cells were cultured with D-MEM medium supplemented with 10% fetal 
bovine serum (FBS). Transfections were carried out with lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s instructions.
For stable transfection, 293 FlpIn cells were co-transfected with 10 fold excess of pOG44 
plasmid. To select stable transfectants, the cells were expanded by a 1 to 4 dilution one day 
after transfection, grown for one more day and then hygromycin was added to a final 
concentration of 100 µg/ml. For each transfection in the FAS screen, 1.6 µg pZW11 vector 
containing random library were transfected into 293 FlpIn cells in a 15 cm tissue culture 
dish. After selection for 10 days, the positive clones were trypsin digested, pooled and sorted 
using a Cytomation MoFlo high-speed sorter into 96 well plates at one cell per well. The 
survival colonies will be visible after 10 days, and were checked for green fluorescence. The 
total DNAs from GFP positive cells were used for PCR and sequencing. The ISS sequences 
were further analyzed with a computational pipeline as previously described.
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RNA purification and Semi-quantitative RT-PCR
Total RNA was isolated from transfected cells with TRIzol reagent (Invitrogen) followed by 
DNase I (Invitrogen) treatment. Total RNA (2 µg) was then reverse-transcribed with 
SuperScript III (Invitrogen) with poly T primer or gene specific primer (for splicing 
reporter), and one-tenth of the RT product was used as the template for PCR amplification 
(25 cycles of amplification, with trace amount of Cy5-dCTP in addition to non-fluorescent 
dNTPs). The resulting gels were scanned with a Typhoon 8600 Imager (GE Healthcare), and 
analyzed with Image Quant 5.2 software (Molecular Dynamics/GE Healthcare). All 
experiments were repeated at least three times. The primers used to amply GFP based 
minigene reporters were AGTGCTTCAGCCGCTACCC for GFP exon 1 and 
GTTGTACTCCAGCTTGTGCC for exon 3.
RNA affinity purification and identification of trans-factors
The RNA affinity purification method was modified from a protocol of Marzluff’s lab 27. A 
short (~21 nt) RNA fragment containing three copies of ISS exemplar was synthesized with 
5′ biotin followed by two 18-carbon spacers (Ambion/Invitrogen). For each RNA sample, 
approximately 2.5 × 108 HeLa cells (NCCC, Minneapolis) were harvested at ~95% 
confluent and resuspended with ice-cold 2.5 ml resuspension buffer (50 mM Tris-HCl pH 
8.0, 150 mM NaCl). The cells were mixed with 2.5ml 2x lysis buffer (50mM Tris-HCl pH 
8.0, 150mM NaCl, 15 mM NaN3, 1%(V/V) NP-40, 2 mM DTT, 2 mM PMSF, 2x protease 
inhibitor mix) and lysed for 5 min, and then centrifuge at 12000 g for 20 min at 4°C. 
Subsequently 0.75 nmol biotinylated RNA with two 18 atom spacers (purchased from 
Dharmacon) were added and incubated for 2 hrs at 4 °C. We then added 50 µl Streptavidin-
agarose beads (purchased from Sigma) into the mixture and incubated for 2 hrs at 4 °C with 
slow rotation. The beads were rinsed 3 times using 4 ml lysis buffer (50 mM Tris-HCl pH 
8.0, 150 mM NaCl, 15 mM NaN3, 0.5% NP-40, 1 mM DTT, 1 mM PMSF, 1x protease 
inhibitor mix), resuspended in 40 µl final volume, and mixed with 10 µl 5x SDS loading 
buffer. The proteins were then separated with a 10% SDS-PAGE gel and stained with 
coomassie blue. The gels was kept in 3% acetic acid for the further mass spectrometry 
analysis. Bands specific to the ISS RNA but not to controls were excised and the gel slices 
containing the candidate proteins was digested with trypsin following standard protocols. 
Peptides eluted from the gel were analyzed by ESI-MS/MS on a Q-Tof (Micromass) mass 
spectrometer. The in gel digestion and MS was carried out by the UNC Proteomics Center.
Analyze the correlation between ISSs and the tissue specific splicing data
The human tissue sequence data (Body Map 2.0) were obtained from the ENA archive with 
accession number ERP000546 (available at http://www.ebi.ac.uk/ena/data/view/
ERP000546). The 50bp paired end reads were mapped using Tophat and PSI values of 
alternative exons were calculated using MISO 57. Decoy ISS motif sets were generated as 
random permutations of each of the ISS cluster members and the known SREs were 
avoided. ISS sequences and decoys identified in the skipped exon body and in the 200 bases 
following the skipped exon. Significance of overall ISS effect was calculated as the median 
of comparisons between PSI values for events with an ISS and those with a decoy. SE PSI 
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values were taken for each event from the tissue where their gene is most highly expressed. 
Significance of tissue specificity was assessed by a bootstrapping comparison.
Knock down and over-expression of putative trans-factors
The siRNAs were purchased from Dharmacon (On-target SMARTpool, with scramble 
dsRNA controls), and transfections were conducted with Lipofectamine 2000 (Invitrogen) in 
cells grown in 24-well plates. After 48 hours of siRNA transfection, we transfected with 0.2 
µg splicing reporter, and harvested the cells 24 hours after the second transfection for further 
analyses. In over-expression experiments, we co-transfected 0.8 µg expression vector and 
0.2 µg splicing reporters. The cells were harvested after 72 h for further analyses. For the 
rescue experiment, 293T cells were transfected with siRNA or control siRNA. After 48 
hours, we co-transfected FLAG-tagged YB1 and ISS splicing reporters, and collected the 
cells 24 hours after the second transfection for further analysis.
Co-immunoprecipitation of hnRNP L and YB1
FLAG-tagged splicing factors were transfected into 293T cell as described above. After 48 
hours, the transfected cells were lysed in lysis buffer containing 50 mM HEPES, 150 mN 
NaCl (4.38g), 1mM EDTA, 1% (w/v) CHAPS and Sigma protease inhibitor cocktail (with 
or without 50 µg/ml of RnaseA) at room temperature for 10 minutes. The M2 FLAG agarose 
resin (40 µl) was prepared as described by manufacturer instruction, and incubated with 
1000 µl of cell lysate supernatant with gentle agitation at 4 °C for overnight. The IP samples 
were span down at 8000rpm for 30 seconds and washed with wash buffer (50 mM HEPES, 
150 mM NaCl, 0.1% Triton X-100, 10% glycerol, pH to 7.5) for 3 times. Then the proteins 
were eluted with FLAG peptide (200ng/µl) and transferred into a new tube for further 
analysis.
Exon and intron datasets
The exon and intron datasets were generated using similar filters as described earlier 23. The 
A3Es and A5Es were further filtered by requiring that the longer isoform differ from the 
shorter isoform by at least 6 bases, and SEs were required to be at least 6 bases in length. 
The following numbers of orthologous human/mouse exon pairs were obtained using our 
criteria: 1232 A5Es, 1408 A3Es, 2964 SEs and 44368 CEs. See supplemental method for 
details in computational analyses.
Positional frequency of ISS in different pre-mRNA locations
The ISS-kmers in each group were analyzed separately for the positional frequency along 
the pre-mRNA of different exon/intron dataset. The first and last 60-nt of exons, together 
with the 200 nt flanking introns were used in the analyses. The positional frequency was 
defined as number of transcripts that contain certain set of ISS k-mers divided by the total 
number of transcripts in the position under consideration. To smooth the data, the average 
frequency in a 10-nt window was plotted.
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The hnRNP A0, A1, A2, D0 and DL were cloned into pT7HtB expression vector with 6xHis 
tag and expressed in E. coli BL21(DE3) strain. The proteins were purified into >90% purity 
with His GraviTrap Kit (GE Health Care) following manufacturer’s instruction. The purified 
protein was buffer exchanged to remove excess immidazole and stored at 4 °C in storage 
buffer (20mM HEPES pH 7.4 0.5M NaCl, 10% glycerol and 2mM DTT).
The 5′-biotynalyed RNAs were synthesized by Dharmacon and immobilized at 150 fmols 
per flow cell on a Biacore streptavidine coated chip (Sensor Chip SA, GE Health Care). A 
control flow cell was loaded with a 21nt CA-rich control sequence, and all the SLR response 
were normalized to the controls. All experiments were done on Biacore 2000 platform for at 
least twice in every concentration, and the data were fitted with BIAevaluation software. 
The protein is diluted to its final concentration by HBS-EP buffer (GE Health Care, Cat No. 
BR-1001-88) prior to experiments to avoid bulk shift. Data acquisition was performed using 
Kinject mode at a flow rate of 50 µl/min in the same running buffer. The surface is 
regenerated using 100 µl injection of 2M NaCl followed by 200 µl of running buffer.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. A fluorescence-activated screen for intronic splicing silencers (FAS-ISS) identifies 102 
unique ISS 10mers
(a) Test of the reporter system. Two known ISS sequences: Test 1 (PTB binding site 
TCCTCCTCCA) and Test 2 (hnRNP A1 binding site, TAGGTAGGTA), and an arbitrary 
control sequence (ACCTCAGGCG) were inserted into the GFP-based reporter (pZW11) 
and transiently transfected into 293T cells. The fraction of GFP-positive cells was measured 
with flow cytometry 24 h after transfection (mean and standard deviation of 3 or more 
replicates shown). (b) Measurement of splicing with RT-PCR using the RNA templates 
purified from the transfected cells and primers targeting exons 1 and 3 of reporter. (c) 
Chromatogram from sequencing of the random 10mer region of minigene. DNAs amplified 
by PCR from stably transfected 293FlpIn cells shows the randomness of the initial library 
Wang et al. Page 18













prior to screening. Sequences around the insertion region (positions 480–489) are shown. (d) 
Diagram of screening strategy and resulting ISS motifs. The 102 unique ISS 10mers 
identified through FAS-ISS were clustered based on the sequence similarity using 
ClustalW2. The 16 ISS 10mers that were reinserted into the original construct and retested 
for ISS activity by transient transfection are indicated (red asterisks).
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Figure 2. Identification of core ISS motifs and exemplars and validation of activity
(a) Over-represented oligonucleotide k-mers were extracted from FAS-ISS 10mers and 
clustered based on sequence similarity. The consensus motifs, the exemplars (representative 
6- or 7-mers) and tested mutations for each group are listed at right. (b) The ISS exemplar 
and mutant from each group were inserted into the pZW11 plasmid, transiently transfected 
into 293T cells, and splicing was assessed by flow cytometry as the fraction of GFP positive 
cells, or (c) by semi-quantitative RT-PCR (sqRT-PCR). The percent-spliced-in (PSI) values 
of three independent experiments are shown beneath a representative gel. Error bars, s.d.; 
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n=3. (d)Validation of ISS activity in a second cell type. HeLa cells were transfected with 
pZW11 containing ISS exemplars and their mutants, and the inclusion of the test exon was 
determined by sqRT-PCR. Error bars, s.d.; n=3. (d) Validation of ISS activity in a 
heterologous intron context. Two copies of ISS exemplars (Supplementary Table 3) from 
each group were inserted downstream of a cassette exon in a different splicing reporter 
(pZW2C, see Methods) and transfected into 293T cells, followed by sqRT-PCR as above. 
Four neutral sequences that did not match known SREs (Supplementary Table 4) were used 
as negative controls. Error bars, s.d.; n=3.
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Figure 3. ISS motifs regulate splicing from an exonic context
(a) FAS-ISS motifs can function as ESEs or ESSs. Two copies of ISS exemplars were 
inserted into the test exon of a modular splicing reporter 55, and transfected into HeLa and 
293T cells. The resulting PSI values divided by the mean of 3 negative controls are shown 
as “relative exon inclusion” levels (Supplementary Table 4). The mean and s.d. of three 
independent transfections are shown. (b) FAS-ISS motifs can regulate alternative 5′SS. A 
single copy of the exemplar motif from each group was inserted between two alternative 
5′SS of a minigene reporter 23 and transfected into HeLa and 293T cells. The observed PSI 
value – defined as the fractional use of the proximal (downstream) 5′SS – was measured by 
sqRT-PCR and divided by that observed in controls to give relative proximal 5'SS usage 
(Supplementary Table 4). Error bars, s.d.; n=3.
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Figure 4. Classification of ISSs based on genomic distribution yields clusters with similar 
context-dependent activity
(a) Principal component analysis (PCA) of relative enrichment in 13 pairs of pre-mRNA 
regions. Relative enrichment between each pair of regions (e.g., SE relative to CE) were 
converted to a vector of 13 z-scores for each ISS motif, which were analyzed by standard 
PCA. ISS groups were clustered based on their positions in the space of the first two 
principal components, which explain 86% of the variance. Both axes were labeled with z-
scores (unitless). (b) Summary of the distributional biases and context dependent activity of 
each ISS group. Diagrams representing constitutive exons, skipped exons and introns are 
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shown adjacent to each motif in order from highest (above) to lowest motif abundance, 
followed by diagrams representing the distribution of the motif from 5' to 3' ends of exons. 
The activities of each ISS motif in different pre-mRNA locations based on data from Figure 
3 and Supplementary Table 5 are listed at right (the ½ indicates that motif B had ESE 
activity in 1 of 2 cell lines tested). The ISS motif labels are color-coded according to the 
PCA clusters shown in panel A.
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Figure 5. Identification and validation of ISS-associated splicing repressors
(a) Diagram of protein identification procedure. (b) Affinity purification using motif U (CA-
rich) and its mutant as bait incubated with extracts from 293T and HeLa cells. Four specific 
bands were excised for mass spectrometry, yielding peptides from the proteins listed at right. 
(c) RNAi analysis of the putative splicing regulatory factors. Derepression of the target exon 
is observed following knockdown of hnRNP L and/or YB-1. Results for reporters containing 
another ISS (motif D) as a specificity control are shown at right. The mean and s.d. of PSI 
values measured by semi-quantitative RT-PCR from three independent experiments are 
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shown below a representative gel in all panels c, d and f (error bars, s.d.; n=3). (d) RT-PCR 
experiments showing the over-expression of trans-factors specifically inhibits exon 
inclusion in reporters with the cognate ISS. Reporters contain ISSs of other group were used 
as a specificity control. (e) Co-immunoprecipitation in 293T cells using anti-Flag antibody 
for precipitation and antibodies against endogenous proteins for detection. The cells were 
lysed in the absence or presence of RNase A. (f) RT-PCR experiments showing that over-
expression of YB-1 reversed the splicing derepression phenoptype caused by RNAi of 
hnRNP L. The splicing reporters containing cognate ISS (group U) or control ISS (group D) 
were used as a specificity control.
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Figure 6. ISSs are recognized by a complex, overlapping network of factors
(a) Interactions between putative splicing factors and all ISS groups were represented by 
solid lines (dashed lines represent interactions inferred from the literature), yielding a many-
to-many connectivity map encompassing all 10 ISSs and their cognate factors. (b) Surface 
plasmon resonance presenting direct RNA-protein binding between ISS exemplars and 
proteins of the hnRNP A and D families. Three different protein concentrations (50, 100 and 
200 nM, from bottom to top in each panel) were injected at a flow rate of 50 µl/min for 120 
s. For hnRNP A1, 20, 40, and 80 nM were used to compensate for the strong binding signal. 
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(c) RT-PCR results showing that tethering RS and Gly-rich to a downstream intronic 
location can repress splicing. Fusion proteins consisting of a PUF domain fused to an RS or 
Gly-rich domain were assayed for their effects on splicing. Two target 8mers, UGUAUGUA 
and UUGAUAUA recognized respectively by PUF(3-2) and PUF(6-2), were inserted into 
the splicing reporter pZW2C and co-transfected with the indicated fusion proteins into 293T 
cells. All combinations of fusion proteins and targets were tested, with matching PUF-target 
pairs indicated by same colors (blue or black). The PUF domains alone and empty vector 
served as negative controls. Right panel, fusions between PUF(6-2) and a variety of RS and 
Gly-rich domains were tested. Error bars, s.d.; n=3.
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Table 1










A CTCCTC hnRNP I/PTB2 (4 RRM + Ala-rich)
B TACAGCT Nono (2 RRM) La protein
YB-1 (CSD)
hnRNP I/PTB (4 RRM + Ala-rich)
C CTTCAG SFPQ (2 RRM + Gln/Glu/Pro-rich) Nucleolin
hnRNP UL1 (Gly-rich + Pro-rich)
hnRNP H1 (3 RRM + Gly-rich)
hnRNP A1 (2 RRM + Gly-rich)
hnRNP A2/B1 (2 RRM + Gly-rich)
D GAACAG GRSF-1 (3 RRM + Ala-rich) CSDE1
hnRNP F (3 RRM)
SFRS1 (2 RRM + Gly-rich)
RBM45/CELF-3 homolog (3 RRM)
E CAAAGGA SFRS1 (2 RRM + Gly-rich) several U1 snRNP core
proteins (e.g., U1-70k,
U1 snRNP protein A
and C, SmD1, SmD2)
hnRNP Q (3 RRM)
hnRNP A1 (2 RRM + Gly-rich)
hnRNP A2/B1 (2 RRM + Gly-rich)
hnRNP H1 (3 RRM + Gly-rich)
hnRNP F (3 RRM)
FUS
F AGATATT KHSRP (4 KH + Gly-rich) La protein
DAZAP1 (2 RRM + Pro-rich)
hnRNP D0 (2 RRM + Gly-rich)
hnRNP A0 (2 RRM + Gly-rich)
hnRNP A1 (2 RRM + Gly-rich)
hnRNP A2/B1 (2 RRM + Gly-rich)
hnRNP A3 (2 RRM + Gly-rich)
CIRBP (1 RRM + Gly-rich)
G3BP-1 (1 RRM + Gly-rich)
G3BP-2 (1 RRM + Gly-rich)
G ACATGA G3BP1 (1 RRM + Gly-rich) GTF2I
hnRNP L (3 RRM + Gly-rich + Pro-rich)
H AATTTA DAZAP1 (2 RRM + Pro-rich) La protein
hnRNP A0 (2 RRM + Gly-rich)























hnRNP D0 (2 RRM + Gly-rich)
hnRNP DL (2 RRM + Gly-rich)
hnRNP A1 (2 RRM + Gly-rich)
hnRNP A2/B1 (2 RRM + Gly-rich)
hnRNP A3 (2 RRM + Gly-rich)
I AGTAGG DAZAP1 (2 RRM + Pro-rich) DHX36
hnRNP A1 (2 RRM + Gly-rich)
hnRNP A2/B1 (2 RRM + Gly-rich)
hnRNP A3 (2 RRM + Gly-rich)
hnRNP H1 (3 RRM + Gly-rich)
hnRNP D0 (2 RRM + Gly-rich)
hnRNP DL (2 RRM + Gly-rich)
FUS




Characteristic RNA binding or splicing regulatory protein motifs are indicated (RRM: RNA Recognition Motif; CSD: Cold shock domain; Gly-
rich: Glycine rich motif; etc.).
2
Based on the literature rather than affinity purification/mass spec.
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